EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, electroCore's enterprise value is $24.87 Mil.
electroCore's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-18.24 Mil. Therefore, electroCore's EV-to-EBITDA for today is -1.36.
The historical rank and industry rank for electroCore's EV-to-EBITDA or its related term are showing as below:
ECOR'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -15.82 Med: -0.93 Max: 0.33
Current: -1.36
During the past 8 years, the highest EV-to-EBITDA of electroCore was 0.33. The lowest was -15.82. And the median was -0.93.
ECOR's EV-to-EBITDA is ranked worse than 100% of 486
companies
in the Medical Devices & Instruments industry
Industry Median: 15.405
vs ECOR: -1.36
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
electroCore EV-to-EBITDA Historical Data
The historical data trend for electroCore's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of electroCore's EV-to-EBITDA
For the Medical Devices subindustry, electroCore's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
electroCore's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, electroCore's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where electroCore's EV-to-EBITDA falls into.
electroCore EV-to-EBITDA Calculation
electroCore's EV-to-EBITDA for today is calculated as:
electroCore's current Enterprise Value is $24.87 Mil.
electroCore's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-18.24 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
electroCore (NAS:ECOR) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
electroCore's PE Ratio for today is calculated as:
electroCore's share price for today is $5.76.
electroCore's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.500.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of electroCore's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ECOR has been successfully added to your 